Viagron 100 - Hilma Biocare

Pfizer introduced Sildenafil citrate in 1989 as Viagra a PDE5 inhibitor that boosts blood flow, through the NO/cGMP pathway. Expected for angina treatment initially it gained approval in 1998 for managing dysfunction (ED) following clinical trials. Viagra emerged as the choice for ED treatment presently providing an efficient solution for countless men, with its proven therapeutic benefits.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Viagron 100 by Hilma Biocare, consult with your doctor or healthcare professional.